ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.00
2.17%
Dow Jones
38,675.68
1.18%
Brent Oil
82.765
0.00%
Bitcoin
63,692.15
1.28%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. GH Research PLC (GHRS) Quote

GH Research PLC

GH Research PLC (GHRS)

NASDAQ
11.68
0.49
(4.38%)
Closed May 04 4:00PM
Delayed by 15 minutes
11.69
0.01
(0.09%)
After Hours: 7:59PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
11.68
Bid
9.42
Ask
12.63
Volume
132,797
11.29 Day's Range 12.39
5.05 52 Week Range 14.70
Market Cap
608.209M
Previous Close
11.19
Open
11.29
Last Trade
3
@
11.86
Last Trade Time
Financial Volume
$ 1,543,137
VWAP
11.6203
Average Volume (3m)
123,542
Shares Outstanding
52,028,145
Dividend Yield
-
PE Ratio
-17.09
Earnings Per Share (EPS)
-0.68
Revenue
-
Net Profit
-35.59M

About GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.ghres.com
Headquarters
Dublin, Irl
Founded
1970
GH Research PLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GHRS. The last closing price for GH Research was $11.19. Over the last year, GH Research shares have traded in a share price range of $ 5.05 to $ 14.70.

GH Research currently has 52,028,145 shares outstanding. The market capitalization of GH Research is $608.21 million. GH Research has a price to earnings ratio (PE ratio) of -17.09.

GH Research (GHRS) Options Flow Summary

GHRS Options Flow

Overall Flow

Bullish

Net Premium

99k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

GHRS Latest News

More News

GH Research Reports First Quarter 2024 Financial Results and Provides Business Updates

Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in Q3 2024 and of 6-month open-label extension phase in Q1...

May 03 2024
GlobeNewswire Inc.

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

March 07 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

February 29 2024
Edgar (US Regulatory)

GH Research Reports Full Year 2023 Financial Results and Provides Business Updates

Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in Q3 2024Phase 2a clinical trial of GH001 in postpartum...

February 29 2024
GlobeNewswire Inc.

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

February 16 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

January 18 2024
Edgar (US Regulatory)

GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression

DUBLIN, Ireland, Jan. 18, 2024 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and...

January 18 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

January 05 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

November 13 2023
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

November 09 2023
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.2111.556829035310.4712.3910.365673811.38573594CS
40.635.7013574660611.0512.3910.37331511.21800087CS
123.6846812.396.821235429.80999128CS
264.6265.43909348447.0612.395.051160368.21693296CS
522.7130.21181716838.9714.75.05911659.27876271CS
156-10.32-46.90909090912230.435.058755813.85185752CS
260-10.32-46.90909090912230.435.058755813.85185752CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BENFBeneficient
$ 6.8001
(254.17%)
31.01M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M
SHOTWSafety Shot Inc
$ 0.45
(45.16%)
644
AIPArteris Inc
$ 8.185
(38.03%)
1.11M
RGFReal Good Food Company Inc
$ 0.85
(37.32%)
4.26M
MNDRMobile health Network Solutions
$ 3.33
(-84.91%)
18.76M
NUVOHoldco Nuvo Group DG Ltd
$ 2.00
(-57.54%)
1.04M
SPTSprout Social Inc
$ 28.82
(-40.15%)
13.47M
UNITUniti Group Inc
$ 4.441
(-26.35%)
21.07M
IPDNProfessional Diversity Network Inc
$ 1.29
(-24.12%)
662.59k
AAPLApple Inc
$ 183.38
(5.98%)
163.22M
SQQQProShares UltraPro Short QQQ
$ 11.08
(-5.94%)
154.59M
JAGXJaguar Health Inc
$ 0.3164
(7.91%)
142.47M
NKLANikola Corporation
$ 0.6526
(6.55%)
106.88M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M

Discussion

View Full Feed
glenn1919 glenn1919 15 seconds ago
BLFY..............................https://stockcharts.com/h-sc/ui?s=BFLY&p=W&b=5&g=0&id=p86431144783
BFLY
Tootall7 Tootall7 28 seconds ago
Well that sucks man, I always looked forward to your post
SPY
cjstocksup cjstocksup 45 seconds ago
https://x.com/JudiciaryGOP/status/1785743489747042791
ap17 ap17 2 minutes ago
Exactly, his attempt at timing the market is nothing short of an EPIC FAILURE!
SHIBUSD
havnagoodtime havnagoodtime 2 minutes ago
To the hopium addicts...courtesy of Donald Fagen and Walter Becker >>

Now you swear and kick and beg us that you're not a gamblin' man
Then you find you're back in Vegas with a handle in your hand
Your black cards can make you money so you hide them when you're able
IGPK
PENNY PIRATE PENNY PIRATE 2 minutes ago
"De-Centralized Complete Gold Crypto Ecosystem" with Confirmed Gold Mines, Gold/Silver Stockpile, Gold Bullion, Available Cash, Gold Backed NFTs, Gold Backed AABBG Tokens, Dividends Distributed and More Approved! An Exchange Being Readied for Buying, Selling, Trading, Saving & Sending Cryptos to Fri
AABB
al44 al44 2 minutes ago
Young Democrats Warn Biden to Stand With Gaza – Or Else

Young voters seem fed up with Biden for now, but will it matter come November?

by James Fite | May 4, 2024


Young Democratic voters have a warning for President Joe Biden: Change course on the
cjstocksup cjstocksup 3 minutes ago
https://x.com/elonmusk/status/1786054505873781005
ImjinBridger ImjinBridger 3 minutes ago
$1 per share is definitely possible by 6/30/24.
I think so too. If progression continues successfully the completion of the first BAM-1 production run should be around the middle of June. That leaves a couple weeks for Kim to compose the most important PR since the Notre Dame PC. Of course we
KBLB
glenn1919 glenn1919 3 minutes ago
PROK..............................https://stockcharts.com/h-sc/ui?s=PROK&p=W&b=5&g=0&id=p86431144783
PROK
MetaMonster MetaMonster 3 minutes ago
RNAZ Move to multiple dollars when it has been so beaten down despite making progress and the sector is hot on acquisitions.
RNAZ
bull runs bull runs 3 minutes ago
Your posts sounds like I’m FJB and I approve this message. 😂
DJT
BullNBear52 BullNBear52 4 minutes ago
Gray proving to be ace Cards need with 7 scoreless frames
1:53 AM EDT
John Denton
John Denton
https://www.mlb.com/cardinals/news/sonny-gray-throws-seven-scoreless-innings-vs-white-sox

His seven scoreless innings Friday lowered his season ERA to a stunning 0
LOVE*PINK LOVE*PINK 5 minutes ago
Reggie James - Perspectives podcast. Whether you're a seasoned entrepreneur, a budding professional, or simply someone hungry for knowledge, Perspectives has something for everyone. Enjoy!

https://twitter.com/ReggieJames99

https://podcasters.spotify.com/pod/show/reggie-
DBMM
Alexulf Alexulf 5 minutes ago
AI and stocks, analysing the different aspects of a companies value.

Text below is a sum up by AI; calculations of PlantX reported filings 2023.

The previous year, PlantX focused on profitable growth,
resulting in strong financial performance.

al44 al44 6 minutes ago
The Green-Driven Surrender of the West

David Blackmon
May 04, 2024
·
Members of the G7 economic alliance, meeting in Turin, Italy, agreed Tuesday to end usage of coal for power generation by the year 2035, a mere 11 years into the future. But, as with so many inte
StocksNcash StocksNcash 7 minutes ago
https://aitx.ai/steves-aitx-weekend-update-may-4-2024/
AITX
glenn1919 glenn1919 8 minutes ago
NKTR.........................https://stockcharts.com/h-sc/ui?s=NKTR&p=W&b=5&g=0&id=p86431144783
NKTR
Arti3boy Arti3boy 8 minutes ago
Once you ignore all the noise this channel sounds so much better
NSAV
Jetmek_03052 Jetmek_03052 9 minutes ago
Pump PUMP PUMP!!!
DBMM
StocksNcash StocksNcash 9 minutes ago
AITX$ company is growing 👍
AITX
EyeInTheSky EyeInTheSky 10 minutes ago
Ain't no body reading all that 😂
NSAV
redspeed redspeed 10 minutes ago
The warrants that were given out in March, beginning of June, end of June, beginning of August do expire in 18 months from the date of issue so currently none have expired.

The strike price, which is also known as the exercise price is $0.005, which is the price you can purchase the
MRES

Your Recent History

NASDAQ
GHRS
GH Research
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved